WAI CHUN BIOTEC (00660) announced its annual results for the year ended June 30, 2025. The group recorded revenue of HK$377 million, representing a year-on-year increase of 1.92%. Loss attributable to owners of the company was HK$14.623 million, down 66.93% year-on-year. Loss per share was HK$0.0843. The announcement noted that the improvement in losses was primarily due to a significant reduction in impairment losses on non-financial assets during the reporting period.